Showing results (341-350 of 538) with videos related to

Sort By:
Pageof 54
Joint Bone Spine|April 22, 2006
Nonpharmacological treatments in early rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinionLaure Gossec, Stephan Pavy, Thao Pham, et al.
Clinical Rheumatology|May 10, 2022
Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational studyRieke Alten, Xavier Mariette, René-Marc Flipo, et al.
Frontiers in Immunology|December 21, 2018
Low Percentage of Signal Regulatory Protein α/β+ Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis PatientsLaura Magill, Marsilio Adriani, Véronique Berthou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 28, 2023
Association Between Bruton's Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sjögren's SyndromePierre-Marie Duret, Cedric Schleiss, Lou Kawka, et al.
Clinical and Experimental Immunology|April 17, 2021
Long-term exposure to monoclonal anti-TNF is associated with an increased risk of lymphoma in BAFF-transgenic miceGaetane Nocturne, Bineta Ly, Audrey Paoletti, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 15, 2020
Interleukin-7/Interferon Axis Drives T Cell and Salivary Gland Epithelial Cell Interactions in Sjögren's SyndromeElodie Rivière, Juliette Pascaud, Alexandre Virone, et al.
Joint Bone Spine|May 13, 2006
Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinionThao Pham, Laure Gossec, Arnaud Constantin, et al.
Annals of the Rheumatic Diseases|April 8, 2022
Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndromeRaphaele Seror, Gabriel Baron, Marine Camus, et al.
Joint Bone Spine|April 22, 2006
Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinionStephan Pavy, Arnaud Constantin, Thao Pham, et al.
European Journal of Internal Medicine|July 29, 2018
Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective studyMaxime Samson, Hervé Devilliers, Kim Heang Ly, et al.
Pageof 54